Boston, MA, United States of America

Srinivas Ganta

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Detection by Srinivas Ganta

Introduction

Srinivas Ganta is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of cancer diagnostics through his innovative work. His research focuses on developing advanced technologies that can aid in the early detection of cancer lesions.

Latest Patents

Srinivas Ganta holds a patent for a multimodal diagnostic technology aimed at identifying early-stage cancer lesions. The patent describes compositions of a multimodal detection agent and methods for fabricating the same. This detection agent comprises a plurality of metallic nanoparticles attached to a surface of a polymeric carrier. Additionally, the detection agent includes one or more target-specific binding agents attached to the metallic nanoparticles or the polymeric carrier. This innovative approach has the potential to enhance the accuracy of cancer diagnostics.

Career Highlights

Srinivas Ganta is affiliated with Northeastern University, where he contributes to research and development in the field of biomedical engineering. His work is characterized by a commitment to advancing medical technology and improving patient outcomes. With a focus on practical applications, he aims to bridge the gap between research and clinical practice.

Collaborations

Srinivas has collaborated with notable colleagues, including Mansoor M Amiji and Pei-Chin Tsai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Srinivas Ganta's work in multimodal diagnostic technology represents a significant advancement in the fight against cancer. His innovative approach and dedication to research continue to inspire progress in the field of medical diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…